An actor from the popular movie "Mrs. Doubtfire" has lost more than 100 pounds. The 1990s movie "Mrs. Doubtfire" starred the ...

Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...

"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity." ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

According to Eli Lilly, the study showed that both medications offer significant weight loss benefits, but people treated with Zepbound lost more weight than those on Wegovy after 72 weeks of ...

The trial demonstrated that Zepbound led to a significantly higher weight loss over a 72-week period compared to Wegovy, showcasing its superior efficacy in treating nondiabetic obese or ...

Zepbound (tirzepatide) is a prescription drug that’s used for weight loss in certain adults. Zepbound comes as a liquid solution inside prefilled injection pens. You’ll inject the drug under ...

Eli Lilly (NYSE:LLY) has been making headlines recently with its weight-loss drug Zepbound (tirzepatide). Eli Lilly's weight-loss drug Zepbound (tirzepatide) just proven to be more effective than Novo ...

Share on Pinterest Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Shelby Knowles/Bloomberg via Getty Images Zepbound led to more long ...